Macromolecular juggling by ubiquitylation enzymes by Sonja Lorenz et al.
To catalyze multistep reactions some metabolic enzymes 
undergo major structural rearrangements. By 
disassembling the interfaces between domains and then 
reassembling them differently, these enzymes create 
distinct active sites and recognize multiple substrates 
sequentially. Having one enzyme that can restructure 
itself to carry out two or more steps in sequence is 
presumably more efficient than parsing out the tasks to 
separate enzymes and also reduces the risk of losing 
intermediate products, particularly those that are 
chemically labile. Catherine Drennan and colleagues 
recently introduced the term ‘molecular juggling’ [1] to 
describe the large structural rearrangements of enzymes 
involved with B12-dependent methyl transfer reactions 
[1-3]. One of us (JK) encountered a similar phenomenon 
in the early 1990s when studying the bacterial thioredoxin 
reductase enzyme [4-6]. Other examples of molecular 
juggling are provided by the ANL (acyl-CoA synthetases, 
non-ribosomal peptide synthetase adenylation domains, 
and luciferase) superfamily of adenylating enzymes (for 
review, see [7]). The last decade has seen a dramatic 
expansion in structural information for a set of enzymes 
that control the addition of ubiquitin, a small protein, to 
target proteins. This new structural window into 
ubiquitylation enzymes has revealed them to be 
molecular jugglers of a most sophisticated kind, as noted 
for one class of these enzymes by Christopher Lima and 
coworkers [8]. In this review we survey what we have 
learned from crystallographic studies about the large 
conformational changes in ubiquitylation enzymes.
Ubiquitylation controls protein trafficking and 
degradation as well as complex signaling pathways, such 
as DNA repair and immune responses (for reviews, see 
[9,10]). The diverse physiological roles of ubiquitin 
originate, at least in part, from the many ways by which it 
can be attached to target proteins. Target proteins may be 
tagged with one or several individual ubiquitin molecules 
or with polymeric ubiquitin chains. These chains are 
linked through isopeptide bonds between the carboxyl 
terminus of one ubiquitin molecule and a primary amino 
group on another. Ubiquitin contains seven lysine 
residues and a free amino terminus, so the chains can 
have many different topologies, depending on the 
enzymes involved in assembling them. The various types 
of ubiquitin modifications are recognized by different 
downstream effectors in the cell and trigger distinct 
functional outcomes (for reviews, see [11,12]). Further 
diversity arises from the existence of several ubiquitin-
like protein modifiers, such as SUMO (small ubiquitin-
like modifier) and NEDD8 (neural precursor cell 
expressed, developmentally down-regulated 8) that 
utilize their own enzymatic machineries and are 
associated with distinct physiological responses (for 
review, see [13]). We shall draw on structural information 
from studies on all three of these modifiers, and will, 
where appropriate, refer to ubiquitin and ubiquitin-like 
proteins collectively as ‘Ubl’.
Ubiquitylation is accomplished through a catalytic 
cascade involving ubiquitin-activating enzymes (E1), 
ubiquitin-conjugating enzymes (E2), and ubiquitin ligases 
(E3) (for review, see [14]). The human proteome contains 
two E1 enzymes [15-18], approximately 40 E2 enzymes 
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[19], and over 600 E3 enzymes [20], the combination of 
which accounts for the large variety of ubiquitin 
modifications. To transfer ubiquitin from one carrier to 
the next one, ubiquitylation enzymes sequentially form and 
reorganize protein-protein interfaces. We thus use the 
term ‘macromolecular juggling’ to describe these actions.
E1 enzymes catalyze the formation of a thioester-linked 
complex between ubiquitin and E2 enzymes (for review, 
see [14]) (Figure 1a). This process begins by activation of 
the carboxyl terminus of ubiquitin by adenylation, 
followed by a thioesterification reaction in which 
ubiquitin is conjugated to a cysteine residue at the active 
site of the E1 enzyme. Ubiquitin is then transferred to the 
active site cysteine of an E2 enzyme in a trans-
thioesterification reaction.
The transfer of ubiquitin from ‘charged’ E2 enzymes 
onto target proteins is mediated by enzymes of the E3 
family. The common outcome of E3-catalyzed reactions 
is an isopeptide linkage between the carboxyl terminus of 
ubiquitin and a primary amino group on a target protein. 
However, E3 enzymes vary significantly in size and 
subunit composition and follow different mechanisms 
(for reviews, see [21,22]): RING (really interesting new 
gene) domain-containing E3 enzymes and the related U-
box E3s interact with charged E2 enzymes and target 
proteins simultaneously and facilitate direct ubiquitin 
Figure 1. Ubiquitylation is a multistep reaction. (a) E1 enzymes use ATP to activate the carboxyl terminus of ubiquitin (Ubi) as a high-energy 
anhydride (Ubi-AMP). The E1 active site cysteine then attacks the adenylated ubiquitin to form a thioester intermediate. Subsequently, the active 
site cysteine of the E2 receives ubiquitin via trans-thioesterification. (b) E3 enzymes catalyze the formation of an isopeptide bond between the 
ubiquitin carboxyl terminus and a primary amino group of an acceptor. The acceptor can be a target protein (mono-ubiquitylation/ubiquitin 
chain initiation) or another ubiquitin molecule (ubiquitin chain elongation). Catalysis by HECT- and RBR-type E3 enzymes proceeds through an 
intermediate, in which the ubiquitin carboxyl terminus is thioester-linked to a cysteine residue at the active site of the E3, followed by aminolysis of 
the thioester. In contrast, RING-type E3s catalyze direct transfer of ubiquitin from the E2 active site cysteine to amino groups on the acceptor.
C     O =
O
I -































       




























       
















Lorenz et al. BMC Biology 2013, 11:65
http://www.biomedcentral.com/1741-7007/11/65
Page 2 of 12
transfer from the E2 onto the target protein (Figure 1b). 
In contrast, the mechanism of HECT (homologous to the 
E6-AP C-terminus) domain-containing E3 enzymes 
includes an additional trans-thioesterification step, in 
which ubiquitin is linked to a catalytic cysteine on the E3. 
The resulting charged E3 then transfers ubiquitin to the 
target protein (Figure 1b). A combination of both 
mechanisms is used by the RING-in-between-RING 
(RBR) family of E3s. Like HECT E3s, RBRs contain a 
catalytic cysteine and form a thioester-linked 
intermediate with ubiquitin before passing it on to the 
target protein [23] (Figure 1b). However, they also utilize 
a canonical RING domain to recruit the charged E2 
enzyme (for review, see [22]).
As revealed by a growing body of structural data, E1 
and E3 enzymes undergo striking remodeling of domains 
during their catalytic cycle. In contrast, most E2 enzymes 
are relatively small, single-domain proteins and do not 
utilize large-scale structural changes for Ubl transfer 
[24-26].
We describe the conformational changes of E1 and 
HECT-type E3 enzymes in the first part of this review. 
Unlike E2 or RING-type E3 enzymes, these two classes of 
ubiquitylation enzymes catalyze multistep reactions. 
Structural rearrangements allow these enzymes to bind 
multiple sequential substrates and process them in 
distinct active sites. As reviewed elsewhere [27,28], 
structural flexibility has also been observed in cullin-
RING ligases, a group of multisubunit RING-type E3 
enzymes, which catalyze one-step ubiquitin transfer 
reactions.
In the second part, we describe conformational changes 
that are involved in modulating the activity of 
ubiquitylation enzymes. Such regulatory rearrangements 
are perhaps best understood for E3 enzymes. We have 
chosen to focus on the way structural flexibility is 
exploited in the regulation of the single-subunit RING E3 
Cbl [29,30].
E1 enzymes reorganize domains during their 
catalytic cycle
The catalytic mechanism of E1 enzymes includes three 
reactions that require distinct active site environments: 
(i) adenylation, (ii) thioesterification, and (iii) trans-
thioesterification. Our current understanding of the 
conformational changes that canonical E1 enzymes 
undergo during catalysis stems primarily from 
crystallographic studies carried out by the groups of 
Brenda Schulman [31-36], Christopher Lima [8,37] and 
Hermann Schindelin [38]. These studies were performed 
with different E1 enzymes that operate on ubiquitin and 
its close relatives, SUMO and NEDD8, respectively. All 
three of these E1s appear to follow a conserved general 
mechanism of catalysis, and because of their related 
domain structures they are classified as ‘canonical’ (for 
review, see [39]). In contrast, ‘non-canonical’ E1 enzymes, 
such as the one that is specific for the autophagy-related 
Ubls ATG8 and ATG12 have distinct structures and 
mechanisms [40-43].
Canonical E1 enzymes contain two Rossmann-type 
folds (either as domains within the same polypeptide 
chain or as separate subunits in the context of a 
heterodimer), a domain containing the catalytic cysteine 
(the cysteine domain), and a ubiquitin-fold domain 
[31,37,38] (for review, see [39]) (Figure 2). The two 
Rossmann-type subunits are functionally distinct and 
form a quasi-symmetric dimer that catalyzes the 
modification of a single Ubl molecule at a time. Only one 
subunit, the ‘active’ Rossmann-type subunit, binds the 
ATP that is required for adenylation of the terminal 
carboxyl group of the Ubl. Topologically, the cysteine 
domain is inserted into the active Rossmann-type 
subunit. The two connections between the cysteine 
domain and the Rossmann-type subunit are known as 
the ‘crossover’ and ‘re-entry’ loops and have an important 
role in enabling the movement of the cysteine domain 
during catalysis [8]. The ubiquitin-fold domain 
contributes to the recruitment of the E2 enzyme onto 
which the E1-bound Ubl is transferred in a trans-
thioesterification reaction [31,34,37,38].
An impressive range of crystallographic snapshots of 
various catalytic stages of canonical E1 enzymes have 
outlined the conformational dynamics in this enzyme 
family [8,31,32,35,37,38,44]. Below, we describe the major 
structural changes that facilitate the three chemically 
distinct reaction steps.
The E1 cysteine domain adopts an open 
conformation during Ubl adenylation
E1 enzymes initially activate the carboxyl terminus of 
their Ubl substrates by adenylation. In this reaction, the 
terminal carboxylate of the Ubl attacks the α-phosphate 
of ATP bound to the active Rossmann-type subunit, 
releasing pyrophosphate and generating a Ubl-AMP 
conjugate.
The first structural insights into Ubl recognition by E1 
enzymes came indirectly, from studies on their bacterial 
ancestors, MoeB and ThiF. These proteins participate in 
the biosynthesis of molybdenum cofactor and thiamine 
by adenylating the carboxyl terminus of the ubiquitin-
fold proteins MoeD and ThiS, respectively [45-51]. Unlike 
canonical E1 enzymes, MoeB and ThiF contain two 
catalytically active Rossmann-type subunits [49-51]; the 
structural details of their binding to ubiquitin-fold 
proteins are, however, conserved (for review, see [52]).
Ubl recognition by E1 enzymes involves hydrophobic 
contacts between residues in the active Rossmann-type 
subunit and a hydrophobic patch on the globular core of 
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the Ubl [32,37,38]. e carboxy-terminal flexible tail of 
the Ubl protrudes into a shallow cleft on the E1 surface 
and points toward the ATP binding pocket (Figure 2a), 
where it is clamped tightly by the crossover loop 
connecting the cysteine domain and the active 
Rossmann-type subunit. e ATP binding pocket itself is 
solvent-accessible, which allows the pyrophosphate 
product of the adenylation reaction to diffuse out, 
thereby reducing back-reactions. Residues critical for 
ATP/Mg2+ binding and catalysis are highly conserved 
[31,32,37,38,49,51], but contacts between the Ubl tail and 
the crossover loop vary across different E1 enzymes, and 
contribute to their specificity for particular Ubls 
[32,36,53-55]. Ubiquitin- and NEDD8-specific E1 
enzymes form additional electrostatic contacts with their 
Ubls, which are mediated by unique domains found in 
these enzymes [32,38].
During the adenylation reaction, the cysteine domain 
of the E1 adopts an open conformation in which it makes 
few contacts with the active Rossmann-type subunit, and 
the catalytic cysteine residue is separated from the 
carboxyl terminus of the bound Ubl by over 30  Å 
[8,32,37,38]. In the subsequent thioesterification reaction, 
however, the catalytic cysteine residue is linked to the 
Ubl carboxyl terminus. To accomplish this, the E1 
enzyme must either allow release of the Ubl and diffusion 
towards the catalytic cysteine or, as is the case, major 
domain rearrangements around the bound Ubl.
Figure 2. Conformational rearrangements in E1 enzymes. Cartoon representations of distinct states in the catalytic cycle of canonical E1 
enzymes. (a) The adenylation state based on the crystal structure of NAE1-UBA3 in complex with NEDD8 and ATP/Mg2+ [PDB: 1R4N] [32]. The 
carboxy-terminal tail of the Ubl is in the adenylation site of the active Rossmann-type subunit of the E1, ready to nucleophilically attack the 
α-phosphate of the ATP to form the Ubl-AMP intermediate. The catalytic cysteine residue in the E1 cysteine domain is part of an α-helix and 
is removed from the adenylation site, giving rise to an open conformation of the cysteine domain. (b) The thioesterification state as seen in a 
crystal structure of SAE1-UBA2 and SUMO covalently coupled to an AMP analogue that mimics the tetrahedral intermediate generated during 
thioesterification [PDB: 3KYD] [8]. Mediated by large conformational changes in the crossover and re-entry loops, the cysteine domain is rotated 
with respect to the Rossmann-type subunits. The helix containing the active site cysteine seen in (a) has melted. In this closed conformation of the 
cysteine domain, the catalytic cysteine nucleophile is in position to attack the adenylated carboxyl terminus of the Ubl. The positive dipole of helix 
H2 in the active Rossmann-type subunit (colored purple) is thought to favor this reaction [8]. (c) The trans-thioesterification state as represented by 
a crystal structure of NAE1-UBA3 thioester-linked to NEDD8 and in complex with an additional NEDD8 molecule, an E2 enzyme (Ubc12) and ATP/
Mg2+ [35]. The cysteine domain of the E1 adopts an open orientation similar to the adenylation state (a), but now holds the carboxyl terminus of the 
thioester-linked Ubl close to the E2 active site (a Cys-to-Ala mutant of the E2 was used in this study (see text)). The ubiquitin-fold domain has swung 
away from its position in the previous states (a,b) to accommodate the E2 and contributes to E2 binding. In (a,c) domains found in NAE1-UBA3 but 
not in SAE1-UBA2 were omitted for clarity. To see a rendition of a dynamic transition between the structures shown in the lower panels of (a-c), 
see Additional file 1. As noted in the movie legend, the details of the trajectory linking individual structures is not realistic and is simply meant to 
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The E1 cysteine domain adopts a closed 
conformation for thioesterification
How E1 enzymes switch between conformations that 
facilitate adenylation and thioesterification, respectively, 
was revealed by Christopher Lima, Derek Tan and 
colleagues. They used a chemical strategy to trap a 
covalent complex, in which the SUMO-specific E1 
enzyme (SAE1-UBA2), SUMO and an AMP analogue are 
linked covalently to each other in such a way that the 
active site environment mimics the environment around 
the tetrahedral intermediate that is formed during the 
nucleophilic attack by the catalytic cysteine of the E1 on 
the adenylated SUMO tail (Protein Data Bank (PDB) 
accession [PDB: 3KYD]) [8].
The E1 cysteine domain in this complex is rotated by 
approximately 130° with respect to the open state, now 
adopting a ‘closed’ conformation, in which it forms 
extensive contacts with the active Rossmann-type 
subunit (Figure 2b). Large conformational rearrange-
ments also occur in the crossover and re-entry loops 
connecting the cysteine domain to the active Rossmann 
subunit, and several structural elements in the cysteine 
domain and in both Rossmann-type subunits become 
disordered. In particular, the region of the cysteine 
domain that bears the catalytic cysteine is helical in the 
open state, but becomes extended in the closed 
conformation, enabling the cysteine to reach into the 
adenylation pocket.
How does the active site environment in the closed 
conformation of the cysteine domain stimulate the 
thioesterification reaction? In principle, one would 
expect the presence of basic residues that could promote 
the deprotonation of the cysteine nucleophile. 
Surprisingly, however, the active site environment in the 
closed state does not contain any side chains that could 
potentially act as general acid/base catalysts. Instead, it 
places the catalytic cysteine residue near the amino-
terminal end of helix H2 of the active Rossmann-type 
subunit (Figure 2b). Lima and coworkers propose that the 
positive H2 helix dipole electrostatically stabilizes the 
transition states of both the adenylation and the 
thioesterification reactions [8].
Ubl transfer to the E2 requires reorientation of the 
ubiquitin-fold domain
Before the Ubl protein is passed from the catalytic 
cysteine of the E1 to that of the E2, a second Ubl protein 
is adenylated by the E1 [56,57]. The E1 enzyme thus 
becomes loaded with two Ubl proteins, one that is 
thioester-linked to the catalytic cysteine of the E1 and a 
second one bound non-covalently in the adenylation site. 
Interestingly, binding of the second Ubl protein at the 
adenylation site of the E1 facilitates the transfer of the 
thioesterified Ubl protein to the E2 enzyme [58].
The structural basis for this coupling between the two 
Ubls was revealed by Brenda Schulman and colleagues, 
who solved a crystal structure of the doubly loaded state 
of the NEDD8-specific E1 (NAE1-UBA3) in complex 
with a cognate E2 enzyme (Ubc12) [PDB: 2NVU] [35]. To 
trap this state and prevent NEDD8 transfer onto the E2 
enzyme, the catalytic cysteine residue of the E2 was 
replaced by alanine. In this structure the E1 cysteine 
domain adopts an open conformation, thereby removing 
the thioester-linked Ubl from the adenylation site, as 
required for binding of the second Ubl protein in this 
site. To accommodate the re-oriented thioester-linked 
Ubl and the E2 enzyme, the ubiquitin-fold domain of the 
E1 undergoes a large outward swing with respect to the 
Rossman-type subunits (Figure 2c).
The E2 enzyme is recognized in tripartite fashion by 
the doubly loaded E1 enzyme [35]: one set of interactions 
is contributed by the ubiquitin-fold domain of the E1, a 
second set is provided by the active Rossmann-type 
subunit, and the third involves the Ubl that is thioester-
linked to the active site of the cysteine domain. Upon Ubl 
transfer from the E1 catalytic cysteine to the E2, one face 
of the tripartite interaction between the E1 and the E2 is 
lost: the Ubl, now linked to the E2, no longer provides a 
covalent tether to the E1. The resulting decrease in affinity 
between E1 and E2 presumably facilitates a backward 
swing of the ubiquitin-fold domain of the E1, thereby 
enabling product release. The conformational switch of 
the ubiquitin-fold domain, together with the tripartite, 
Ubl-assisted nature of E2 binding, thus adds directionality 
to the trans-thioesterification reaction. In line with this 
mechanism, mutations that restrict the freedom of 
movement of the ubiquitin-fold domain decrease the 
efficiency of Ubl transfer onto the E2 [34,38]. Contacts 
between the ubiquitin-fold domain and the E2 enzyme 
also contribute to the specificity of E1 enzymes for 
particular Ubls [16,59-61] (for review, see [39]).
Additional file 1: Movie of hypothetical transitions between 
different states in the E1 catalytic cycle (morphed structures 
modified from [PDB: 1R4N, 3KYD, 2NVU]).
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Notably, the crystallographic snapshot of doubly loaded 
E1 in complex with the E2 leaves an estimated 
approximately 20 Å gap between the active site cysteine 
residues of the E1 and the E2 [35], indicating that trans-
thioesterification occurs in another, yet uncharacterized, 
conformation.
HECT E3 enzymes require structural plasticity for 
catalysis
Once ubiquitin has been linked to the E2 enzyme, an E3 
enzyme catalyzes the transfer of ubiquitin to a target 
protein. For E3s in the HECT and RBR families, this 
process involves the formation of an intermediate in 
which ubiquitin is thioester-linked to a catalytic cysteine 
residue of the E3 (Figure 1b). Like E1 enzymes, these E3 
enzymes thus catalyze multistep reactions. Nikola 
Pavletich and coworkers [62] predicted considerable 
structural flexibility in HECT E3 enzymes when they 
determined the first crystal structure of a HECT family 
member, the HECT domain of E6AP in complex with the 
E2 enzyme UbcH7 [PDB: 1C4Z]. HECT domains 
(approximately 40 kDa) consist of two lobes, a large 
amino-terminal or N-lobe containing the E2 binding site 
and a smaller carboxy-terminal or C-lobe bearing the 
catalytic cysteine. In the E2-bound state, the two lobes of 
E6AP were found to adopt an open, ‘L’-shaped 
conformation, giving rise to a >40  Å gap between the 
active site cysteine residues of the E2 and the E3 (Figure 
3a). Transfer of ubiquitin between these sites was thus 
expected to involve conformational rearrangements.
Indeed, the two lobes are fundamentally reorganized 
with respect to each other in a crystal structure of the 
HECT domain of WWP1/AIP solved by Joseph Noel and 
colleagues [PDB: 1ND7] [63]. This HECT domain adopts 
a closed conformation, reminiscent of the letter ‘T’ 
(Figure 3b). A flexible hinge region connecting the two 
HECT lobes enables this remarkable rearrangement, and 
mutations that restrict conformational freedom in this 
region inhibit the ubiquitylation activity of WWP1/AIP 
in vitro, attesting to the functional importance of 
structural flexibility in this enzyme [63]. The transition 
from the open to the closed state of the HECT domain is 
expected to bring the active sites of the E3 and a bound 
E2 closer to each other. However, a remaining gap of 
approximately 17  Å between the catalytic centers of E2 
and E3 (estimated from the crystal structure of WWP1/
AIP and modeling of the E2 according to the E6AP-
UbcH7 structure [62]) indicated additional 
conformational changes yet to be uncovered that would 
allow trans-thioesterification.
Key insights into these structural changes came from 
Brenda Schulman’s group, who determined a crystal 
structure of the HECT-domain of NEDD4L in complex 
with a thioester-linked E2-ubiquitin conjugate [PDB: 
3JVZ] [64]. The complex adopts a compact conformation, 
in which the HECT C-lobe is rotated markedly compared 
to previous structures, and makes contacts with E2-
bound ubiquitin (Figure 3c). This interaction is mediated 
by a conserved hydrophobic surface on the C-lobe of the 
E3 and appears to tether the C-lobe in proximity to the 
E2 – as was hypothesized by Pavletich and colleagues 
[62]. A remaining gap of approximately 8 Å between the 
catalytic centers of E2 and E3 in this structure could 
readily be closed by additional small rotations around the 
flexible hinge region, yielding a functional trans-
thioesterification intermediate.
Crystal structures of several other HECT domains are 
now available, including ‘open-like’ states of Rsp5 [PDB: 
3OLM] [65] and Smurf2 [PDB: 1ZVD] [66], closed states 
of Itch [PDB: 3TUG] and HUWE1 [PDB: 3G1N, 3H1D] 
[67] , two unique states of NEDD4 [PDB: 2XBF, 2XBB] 
[68], and NEDD4L in an apo conformation that 
resembles its trans-thioesterification state with ubiquitin-
charged E2 [PDB: 2ONI] (Figure 3d). Taken together, 
these HECT domain structures show a considerable 
variation in the relative orientations of N- and C-lobes, 
indicating that dynamic rearrangements are a common 
feature in the HECT E3 family. Interestingly, the same is 
true for HECT E3-like proteins found in bacterial 
pathogens [69-71]. These bacterial proteins can interact 
with eukaryotic E2 enzymes in vitro and are thought to 
‘hijack’ the ubiquitylation system upon delivery into the 
cytosol of the eukaryotic host, thereby regulating host 
inflammatory responses [69].
The structural plasticity of HECT-like E3 enzymes in 
both eukaryotic and prokaryotic systems is consistent 
with a functional role for this level of flexibility during 
catalysis. It is possible that domain movements of HECT 
E3s are implicated in the iterative binding and release of 
E2 enzymes or the repositioning of ubiquitin substrates, 
as might be required during the formation of a ubiquitin 
chain [63,64]. The mechanism of ubiquitin chain 
formation by HECT E3 enzymes, however, remains 
controversial and is likely to vary between enzymes 
[72,73].
The structural flexibility of E3 enzymes is 
harnessed for their regulation
Since E3 enzymes require flexibility during their catalytic 
cycle, they can be regulated by processes that restrict 
their flexibility and lock them in particular 
conformations. The HECT E3s Itch and Smurf2, for 
example, are negatively regulated through intra- and 
intermolecular interactions between their catalytic 
HECT domains and preceding WW and C2 domains, 
respectively [74,75]. Autoinhibition is relieved upon 
phosphorylation in the amino-terminal part of Itch [74] 
and binding of Smurf2 to the adaptor protein Smad7, 
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Figure 3. Swinging domains in HECT E3 enzymes. Cartoon representations of crystal structures of various HECT domains. (a) Open, ‘L’-shaped 
conformation of E6AP (E3) in complex with UbcH7 (E2) [PDB: 1C4Z] [62], (b) closed, ‘T’-shaped conformation of WWP1/AIP [PDB: 1ND7] [63], and (c) 
trans-thioesterification complex of NEDD4L with a ubiquitin-E2 (UbcH5B) conjugate [PDB:3JVZ] [64]. In (c) the E2 active site cysteine was mutated 
to serine (colored yellow in our representation), resulting in an oxy-ester linkage with ubiquitin in lieu of the native thioester. (d) Distinct classes of 
C-lobe orientations based on the crystal structures of various HECT domains (WWP1/AIP [PDB: 1ND7], Itch [PDB: 3TUG], HUWE1 [PDB: 3G1N, 3H1D], 
NEDD4L [PDB: 2ONI, 3JVZ], E6AP [PDB: 1C4Z], Rsp5 [PDB: 3OLM], Smurf2 [PDB: 1ZVD], NEDD [PDB: 2XBB]). A second unique C-lobe orientation 
observed for NEDD [PDB: 2XBF] could not be displayed for clarity. In our representation the HECT N-lobes are superimposed and only one of them 
is displayed. Binding partners, such as E2 enzymes or ubiquitin, found in some of the structures are not displayed.
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respectively [75]. Autoinhibitory domain interactions 
have also been identified for E3 enzymes in the RBR [76] 
and RING families (for review, see [77]).
A structural mechanism for regulation of RING-type 
E3 enzymes by posttranslational modifications was first 
described for the multisubunit cullin-RING ligases. As 
suggested by biochemical studies indicative of 
conformational rearrangements [78,79], covalent 
attachment of the Ubl NEDD8 to the cullin subunit 
results in a dramatic re-orientation of the RING domain 
that places the bound E2 adjacent to the substrate, 
thereby activating the ligase [80]. is conformational 
switch is harnessed by various cellular effectors that 
restrict the conformational flexibility of cullin-RING 
ligases (for reviews, see [28,77]). Other RING-type E3 
enzymes are regulated through conformational changes 
that affect their oligomerization state, as demonstrated 
for inhibitor of apoptosis proteins (IAPs) [81,82] and 
tumor necrosis factor receptor-associated factor 
(TRAF6) [83]. We will focus here on the recently 
elucidated role of phosphorylation-induced structural 
rearrangements in the regulation of the single-subunit 
RING E3 enzyme Cbl.
Phosphorylation triggers regulatory domain 
rearrangements in CBL proteins
Cbl proteins (c-Cbl, Cbl-b and Cbl-c) are a family of 
single-subunit RING E3 enzymes that ubiquitylate 
receptor and non-receptor tyrosine kinases and thereby 
regulate both the trafficking and the degradation of these 
kinases (for reviews, see [84,85]). Members of the Cbl 
family share a conserved amino-terminal tyrosine kinase 
binding module that includes an SH2 (Src homology 2) 
domain, as shown by Michael Eck and colleagues [86,87], 
and is connected to the RING domain through a helical 
linker. e SH2 domains of Cbl proteins bind to 
phosphorylated tyrosine residues on substrates, including 
receptor-tyrosine kinases such as the epidermal growth 
factor receptor [88] and the T-cell receptor-associated 
tyrosine kinase Zap70 [86,89]. e RING domain recruits 
the E2 enzyme (for review, see [90]). e first view of how 
RING domains recognize E2 enzymes was provided by 
Nikolai Pavletich and coworkers [91], who determined 
the crystal structure of the tyrosine kinase binding 
module, linker helix and RING domain of c-Cbl in 
complex with a phosphorylated Zap70-derived peptide 
and the E2 enzyme UbcH7 [PDB: 1FBV] (Figure 4b). 
Figure 4. Regulatory rearrangements in Cbl proteins. (a) ‘Closed’ conformation of Cbl based on the crystal structure of the apo c-Cbl amino-
terminal region, comprising the tyrosine kinase binding module, the helical linker region, and the RING domain [PDB: 2Y1M] [29]. The regulatory 
tyrosine, Y371, located in the helical linker region, is buried in a hydrophobic core formed by the SH2 domain and the four-helix bundle in the 
tyrosine kinase binding module. (b) ‘Partially open’ conformation of Cbl based on the co-crystal structure of c-Cbl amino-terminal region with a 
ZAP70-derived phosphopeptide and the E2 enzyme UbcH7 [PDB: 1FBV] [91]. Phosphopeptide binding induces a shift in the SH2 domain that 
perturbs the interface between the helical linker and the tyrosine kinase binding module, probably favoring dissociation of the RING domain from 
the tyrosine kinase binding module and thus increasing the accessibility of the E2 binding surface. (c) ‘Open’ conformation of Cbl based on the co-
crystal structure of phosphorylated c-Cbl bound to a ZAP7-derived phosphopeptide and UbcH5B [PDB: 4A4C] [29]. The phosphorylated regulatory 
tyrosine, Tyr371, interacts with residues in the E2 binding surface of the RING domain. The RING domain is situated on the opposite side of the 
tyrosine kinase binding module compared to (b).
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However, this structure showed a large gap between the 
E2 active site and the substrate peptide, and with no 
information on the spatial orientation of the target 
protein with respect to this peptide, it remained unclear 
how ubiquitin is transferred to the target. Moreover, 
although the co-crystal structure of c-Cbl and UbcH7 
represents a canonical E2-E3 complex, UbcH7 and c-Cbl 
do not form an active and physiologically relevant E2-E3 
pair [92,93]. Another structural puzzle arose from the 
discovery that phosphorylation of Cbl proteins in the 
linker helix region increases their ubiquitin ligase activity 
[88,94-96]. Phosphorylation is incompatible with the 
conformation observed in the first crystal structures 
because the modification site, Tyr371 in c-Cbl, is buried 
at the interface of the tyrosine kinase binding module 
and the helical linker region (Figure 4b).
Two independent studies have recently shed light on 
this discrepancy and have revealed the central role of 
conformational plasticity in Cbl regulation. Danny Huang 
and colleagues [29] presented three crystal structures of a 
c-Cbl fragment comprising the tyrosine kinase binding 
module, the helical linker region and the RING domain: 
(i) the apo form [PDB: 2Y1M], (ii) c-Cbl bound to a 
phosphorylated Zap70-derived peptide [PDB: 2Y1N], 
and (iii) phosphorylated c-Cbl in a ternary complex with 
the phosphorylated Zap70-derived peptide and the E2 
enzyme UbcH5B [PDB: 4A4B]. Fuyuhiko Inagaki and 
coworkers [30] provided nuclear magnetic resonance 
(NMR) and small-angle X-ray scattering (SAXS) data on 
Cbl-b supporting the existence of distinct conformations 
in solution and highlighting the flexible nature of Cbl 
family proteins.
In the absence of substrate, Cbl favors a compact, 
autoinhibited, ‘closed’ conformation, in which contacts 
between the tyrosine kinase binding module and the 
RING domain obstruct the E2 binding site [29,30] (Figure 
4a). Binding of substrate peptide to the SH2 domain 
perturbs the closed conformation, which releases the 
RING domain and opens up the E2 binding site [29,30]. 
This ‘partially open’ state, as represented by the previous 
c-Cbl-UbcH7 co-crystal structure [91], shows a tight 
association between the linker helix region and the 
tyrosine kinase binding module (Figure 4b). In solution, 
however, the partially open state is in a dynamic 
equilibrium with other conformations that make the 
regulatory tyrosine residue accessible [30]. 
Phosphorylation at this site stabilizes a ‘fully open’ state, 
in which the helical linker region is completely 
dissociated from the tyrosine kinase binding module and 
instead makes contact with the RING domain [29,30] 
(Figure 4c). The phosphorylated tyrosine on the linker 
helix forms ionic interactions with lysine residues on the 
RING domain, whose positive charge might otherwise 
repel the positively charged binding surface of the E2 
[30]. The RING domain also undergoes a dramatic re-
orientation relative to the tyrosine kinase binding 
module, which significantly reduces the distance between 
the E2 active site and the bound substrate peptide [29]. 
Taken together, the conformational opening thus 
increases the affinity of Cbl proteins for E2 enzymes as 
well as their catalytic efficiency of ubiquitin transfer.
While these studies reveal how posttranslational 
modifications and allosteric effects can induce a shift in 
the conformational equilibrium of Cbl proteins, it is not 
the end of the story. For c-Cbl and Cbl-b, dimerization 
through their carboxy-terminal ubiquitin-associated 
(UBA) domain is required for them to function in cells 
[97-99]. This raises the intriguing question of whether 
dimerization of Cbl proteins allows them to detect and 
respond to the dimerization or clustering of receptor-
tyrosine kinases upon activation.
Catalytic efficiency and regulation through 
macromolecular juggling
In this review we have highlighted a few of the many 
impressive crystallographic studies delineating the large-
scale conformational changes that underlie the catalytic 
action and regulation of ubiquitylation enzymes. E1 
enzymes reorganize the three-dimensional arrangement 
of their domains to generate the active site environments 
for chemically distinct reactions and to progressively 
alter the affinities for their sequential macromolecular 
substrates. These features presumably allow E1 enzymes 
to achieve efficiency and directionality in the catalysis of 
multistep reactions. Similar mechanisms are likely to be 
used by enzymes in the HECT E3 family, which also rely 
on structural flexibility to catalyze multistep reactions. 
Moreover, conformational rearrangements are important 
in ubiquitylation enzymes that catalyze one-step 
reactions, as seen for members of the cullin-RING family. 
These multisubunit E3 enzymes re-orient individual 
subunits to allow the RING domain to approach target 
proteins of various sizes and to enable the formation of 
ubiquitin chains [100-102] (for reviews, see [27,28]). 
Structural studies on a particularly complex cullin-RING 
E3, the anaphase-promoting complex, are beginning to 
reveal how conformational changes in this giant, 
approximately 1.5 megadalton protein assembly affect 
function [103,104].
The need to efficiently process macromolecular 
substrates unites the various components of the 
ubiquitylation machinery, irrespective of their size and 
complexity. Unlike small metabolites that often interact 
with small surface crevices that can be opened or closed 
through relatively subtle structural fluctuations, protein 
substrates typically utilize large, flat surfaces to bind to 
enzymes. To modulate these surfaces and to actually 
juggle protein substrates without either holding on to 
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them too long or dropping them prematurely presents a 
considerable challenge. Large-scale conformational 
rearrangements appear to have emerged as an 
evolutionary answer.
Note
While this review was in press, Shaun Olsen and 
Christopher Lima published the crystal structure of a 
complex containing Schizosaccharomyces pombe E1 
(Uba1), E2 (Ubc4), and ubiquitin that illuminates the 
structural basis of the final trans-thioesterification step in 
the catalytic cycle of canonical E1 enzymes [105].
Abbreviations
PDB, Protein Data Bank.
Acknowledgements
We acknowledge support by a Leukemia and Lymphoma Society postdoctoral 
fellowship award (SL) and a University of California Cancer Research 
Coordinating Committee Graduate Fellowship (AJC). We thank Dr Tiago Barros 
for assistance with preparation of the movie.
Author details
1Department of Molecular and Cell Biology, University of California, Berkeley, 
CA 94720, USA. 2California Institute for Quantitative Biosciences, University 
of California, Berkeley, CA 94720, USA. 3Department of Chemistry, University 
of California, Berkeley, CA 94720, USA. 4Howard Hughes Medical Institute, 
University of California, Berkeley, CA 94720, USA. 5Physical Biosciences Division, 
Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
Published: 25 June 2013
References
1. Kung Y, Ando N, Doukov TI, Blasiak LC, Bender G, Seravalli J, Ragsdale SW, 
Drennan CL: Visualizing molecular juggling within a B12-dependent 
methyltransferase complex. Nature 2012, 484:265-269.
2. Bandarian V, Pattridge KA, Lennon BW, Huddler DP, Matthews RG, Ludwig ML: 
Domain alternation switches B(12)-dependent methionine synthase to 
the activation conformation. Nat Struct Biol 2002, 9:53-56.
3. Bandarian V, Ludwig ML, Matthews RG: Factors modulating conformational 
equilibria in large modular proteins: a case study with cobalamin-
dependent methionine synthase. Proc Natl Acad Sci U S A 2003, 
100:8156-8163.
4. Kuriyan J, Krishna TS, Wong L, Guenther B, Pahler A, Williams CH, Model P: 
Convergent evolution of similar function in two structurally divergent 
enzymes. Nature 1991, 352:172-174.
5. Waksman G, Krishna TS, Williams CH, Kuriyan J: Crystal structure of 
Escherichia coli thioredoxin reductase refined at 2 A resolution. 
Implications for a large conformational change during catalysis. J Mol Biol 
1994, 236:800-816.
6. Lennon BW, Williams CH, Ludwig ML: Twists in catalysis: alternating 
conformations of Escherichia coli thioredoxin reductase. Science 2000, 
289:1190-1194.
7. Gulick AM: Conformational dynamics in the Acyl-CoA synthetases, 
adenylation domains of non-ribosomal peptide synthetases, and firefly 
luciferase. ACS Chem Biol 2009, 4:811-827.
8. Olsen SK, Capili AD, Lu X, Tan DS, Lima CD: Active site remodelling 
accompanies thioester bond formation in the SUMO E1. Nature 2010, 
463:906-912.
9. Varshavsky A: The Early History of the Ubiquitin Field. Protein Sci 2006, 
15:647-654.
10. Haglund K, Dikic I: Ubiquitylation and cell signaling. EMBO J 2005, 
24:3353-3359.
11. Komander D: The emerging complexity of protein ubiquitination. Biochem 
Soc Trans 2009, 37:937-953.
12. Kulathu Y, Komander D: Atypical ubiquitylation – the unexplored world of 
polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 2012, 
13:508-523.
13. van der Veen AG, Ploegh HL: Ubiquitin-like proteins. Annu Rev Biochem 2012, 
81:323-357.
14. Hershko A, Ciechanover A: The ubiquitin system. Annu Rev Biochem 1998, 
67:425-479.
15. Handley PM, Mueckler M, Siegel NR, Ciechanover A, Schwartz AL: Molecular 
cloning, sequence, and tissue distribution of the human ubiquitin-
activating enzyme E1. Proc Natl Acad Sci U S A 1991, 88:258-262.
16. Jin J, Li X, Gygi SP, Harper JW: Dual E1 activation systems for ubiquitin 
differentially regulate E2 enzyme charging. Nature 2007, 447:1135-1138.
17. Pelzer C, Kassner I, Matentzoglu K, Singh RK, Wollscheid H-P, Scheffner M, 
Schmidtke G, Groettrup M: UBE1L2, a novel E1 enzyme specific for 
ubiquitin. J Biol Chem 2007, 282:23010-23014.
18. Chiu Y-H, Sun Q, Chen ZJ: E1-L2 activates both ubiquitin and FAT10. Mol Cell 
2007, 27:1014-1023.
19. Michelle C, Vourc’h P, Mignon L, Andres CR: What was the set of ubiquitin 
and ubiquitin-like conjugating enzymes in the eukaryote common 
ancestor? J Mol Evol 2009, 68:616-628.
20. Li W, Bengtson MH, Ulbrich A, Matsuda A, Reddy VA, Orth A, Chanda SK, 
Batalov S, Joazeiro CAP: Genome-wide and functional annotation of 
human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that 
regulates the organelle’s dynamics and signaling. PLoS ONE 2008, 3:e1487.
21. Metzger MB, Hristova VA, Weissman AM: HECT and RING finger families of 
E3 ubiquitin ligases at a glance. J Cell Sci 2012, 125:531-537.
22. Wenzel DMD, Klevit RER: Following Ariadne’s thread: a new perspective on 
RBR ubiquitin ligases. BMC Biol 2012, 10:24-24.
23. Wenzel DM, Lissounov A, Brzovic PS, Klevit RE: UBCH7 reactivity profile 
reveals parkin and HHARI to be RING/HECT hybrids. Nature 2011, 
474:105-108.
24. Eddins MJ, Carlile CM, Gomez KM, Pickart CM, Wolberger C: Mms2–Ubc13 
covalently bound to ubiquitin reveals the structural basis of linkage-
specific polyubiquitin chain formation. Nat Struct Mol Biol 2006, 13:915-920.
25. Reverter D, Lima CD: Insights into E3 ligase activity revealed by a SUMO-
RanGAP1-Ubc9-Nup358 complex. Nature 2005, 435:687-692.
26. Yunus AA, Lima CD: Lysine activation and functional analysis of E2-
mediated conjugation in the SUMO pathway. Nat Struct Mol Biol 2006, 
13:491-499.
27. Zimmerman ES, Schulman BA, Zheng N: Structural assembly of cullin-RING 
ubiquitin ligase complexes. Curr Opin Struct Biol 2010, 20:714-721.
28. Schulman BA: Twists and turns in ubiquitin-like protein conjugation 
cascades. Protein Sci 2011, 20:1941-1954.
29. Dou H, Buetow L, Hock A, Sibbet GJ, Vousden KH, Huang DT: Structural basis 
for autoinhibition and phosphorylation-dependent activation of c-Cbl. 
Nat Struct Mol Biol 2012, 19:184-192.
30. Kobashigawa Y, Tomitaka A, Kumeta H, Noda NN, Yamaguchi M, Inagaki F: 
Autoinhibition and phosphorylation-induced activation mechanisms of 
human cancer and autoimmune disease-related E3 protein Cbl-b. Proc Natl 
Acad Sci U S A 2011, 108:20579-20584.
31. Walden H, Podgorski MS, Schulman BA: Insights into the ubiquitin transfer 
cascade from the structure of the activating enzyme for NEDD8. Nature 
2003, 422:330-334.
32. Walden H, Podgorski MS, Huang DT, Miller DW, Howard RJ, Minor DL, Holton 
JM, Schulman BA: The structure of the APPBP1-UBA3-NEDD8-ATP complex 
reveals the basis for selective ubiquitin-like protein activation by an E1. 
Mol Cell 2003, 12:1427-1437.
33. Huang DT, Miller DW, Mathew R, Cassell R, Holton JM, Roussel MF, Schulman 
BA: A unique E1-E2 interaction required for optimal conjugation of the 
ubiquitin-like protein NEDD8. Nat Struct Mol Biol 2004, 11:927-935.
34. Huang DT, Paydar A, Zhuang M, Waddell MB, Holton JM, Schulman BA: 
Structural basis for recruitment of Ubc12 by an E2 binding domain in 
NEDD8’s E1. Mol Cell 2005, 17:341-350.
35. Huang DT, Hunt HW, Zhuang M, Ohi MD, Holton JM, Schulman BA: Basis for a 
ubiquitin-like protein thioester switch toggling E1-E2 affinity. Nature 2007, 
445:394-398.
36. Souphron J, Waddell MB, Paydar A, Tokgöz-Gromley Z, Roussel MF, Schulman 
BA: Structural dissection of a gating mechanism preventing misactivation 
of ubiquitin by NEDD8’s E1. Biochemistry 2008, 47:8961-8969.
37. Lois LM, Lima CD: Structures of the SUMO E1 provide mechanistic insights 
into SUMO activation and E2 recruitment to E1. EMBO J 2005, 24:439-451.
38. Lee I, Schindelin H: Structural insights into E1-catalyzed ubiquitin 
activation and transfer to conjugating enzymes. Cell 2008, 134:268-278.
Lorenz et al. BMC Biology 2013, 11:65
http://www.biomedcentral.com/1741-7007/11/65
Page 10 of 12
39. Schulman BA, Harper JW: Ubiquitin-like protein activation by E1 enzymes: 
the apex for downstream signalling pathways. Nat Rev Mol Cell Biol 2009, 
10:319-331.
40. Taherbhoy AM, Tait SW, Kaiser SE, Williams AH, Deng A, Nourse A, Hammel M, 
Kurinov I, Rock CO, Green DR, Schulman BA: Atg8 transfer from Atg7 to 
Atg3: a distinctive E1-E2 architecture and mechanism in the autophagy 
pathway. Mol Cell 2011, 44:451-461.
41. Hong SB, Kim B-W, Lee K-E, Kim SW, Jeon H, Kim J, Song HK: Insights into 
noncanonical E1 enzyme activation from the structure of autophagic E1 
Atg7 with Atg8. Nat Struct Mol Biol 2011, 18:1323-1330.
42. Noda NN, Satoo K, Fujioka Y, Kumeta H, Ogura K, Nakatogawa H, Ohsumi Y, 
Inagaki F: Structural basis of Atg8 activation by a homodimeric E1, Atg7. 
Mol Cell 2011, 44:462-475.
43. Kaiser SE, Mao K, Taherbhoy AM, Yu S, Olszewski JL, Duda DM, Kurinov I, Deng 
A, Fenn TD, Klionsky DJ, Schulman BA: Noncanonical E2 recruitment by the 
autophagy E1 revealed by Atg7-Atg3 and Atg7-Atg10 structures. Nat 
Struct Mol Biol 2012, 19:1242-1249.
44. Brownell JE, Sintchak MD, Gavin JM, Liao H, Bruzzese FJ, Bump NJ, Soucy TA, 
Milhollen MA, Yang X, Burkhardt AL, Ma J, Loke H-K, Lingaraj T, Wu D, 
Hamman KB, Spelman JJ, Cullis CA, Langston SP, Vyskocil S, Sells TB, Mallender 
WD, Visiers I, Li P, Claiborne CF, Rolfe M, Bolen JB, Dick LR: Substrate-assisted 
inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 
inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol Cell 2010, 
37:102-111.
45. Taylor SV, Kelleher NL, Kinsland C, Chiu HJ, Costello CA, Backstrom AD, 
McLafferty FW, Begley TP: Thiamin biosynthesis in Escherichia coli. 
Identification of ThiS thiocarboxylate as the immediate sulfur donor in the 
thiazole formation. J Biol Chem 1998, 273:16555-16560.
46. Appleyard MV, Sloan J, Kana’n GJ, Heck IS, Kinghorn JR, Unkles SE: The 
Aspergillus nidulans cnxF gene and its involvement in molybdopterin 
biosynthesis. Molecular characterization and analysis of in vivo generated 
mutants. J Biol Chem 1998, 273:14869-14876.
47. Wang C, Xi J, Begley TP, Nicholson LK: Solution structure of ThiS and implications 
for the evolutionary roots of ubiquitin. Nat Struct Biol 2001, 8:47-51.
48. Leimkühler S, Wuebbens MM, Rajagopalan KV: Characterization of 
Escherichia coli MoeB and its involvement in the activation of 
molybdopterin synthase for the biosynthesis of the molybdenum 
cofactor. J Biol Chem 2001, 276:34695-34701.
49. Lake MW, Wuebbens MM, Rajagopalan KV, Schindelin H: Mechanism of 
ubiquitin activation revealed by the structure of a bacterial MoeB-MoaD 
complex. Nature 2001, 414:325-329.
50. Duda DM, Walden H, Sfondouris J, Schulman BA: Structural analysis of 
Escherichia coli ThiF. J Mol Biol 2005, 349:774-786.
51. Lehmann C, Begley TP, Ealick SE: Structure of the Escherichia coli ThiS-ThiF 
complex, a key component of the sulfur transfer system in thiamin 
biosynthesis. Biochemistry 2006, 45:11-19.
52. Hochstrasser M: Evolution and function of ubiquitin-like protein-
conjugation systems. Nat Cell Biol 2000, 2:E153-7.
53. Bohnsack RN, Haas AL: Conservation in the mechanism of Nedd8 activation 
by the human AppBp1-Uba3 heterodimer. J Biol Chem 2003, 
278:26823-26830.
54. Whitby FG, Xia G, Pickart CM, Hill CP: Crystal structure of the human 
ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway 
enzymes. J Biol Chem 1998, 273:34983-34991.
55. Madden MM, Song W, Martell PG, Ren Y, Feng J, Lin Q: Substrate properties 
of ubiquitin carboxyl-terminally derived peptide probes for protein 
ubiquitination. Biochemistry 2008, 47:3636-3644.
56. Haas AL, Rose IA: The mechanism of ubiquitin activating enzyme. A kinetic 
and equilibrium analysis. J Biol Chem 1982, 257:10329-10337.
57. Haas AL, Warms JV, Hershko A, Rose IA: Ubiquitin-activating enzyme. 
Mechanism and role in protein-ubiquitin conjugation. J Biol Chem 1982, 
257:2543-2548.
58. Pickart CM, Kasperek EM, Beal R, Kim A: Substrate properties of site-specific 
mutant ubiquitin protein (G76A) reveal unexpected mechanistic features 
of ubiquitin-activating enzyme (E1). J Biol Chem 1994, 269:7115-7123.
59. Durfee LA, Kelley ML, Huibregtse JM: The basis for selective E1-E2 
interactions in the ISG15 conjugation system. J Biol Chem 2008, 
283:23895-23902.
60. Wang J, Taherbhoy AM, Hunt HW, Seyedin SN, Miller DW, Miller DJ, Huang DT, 
Schulman BA: Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 
interactions in Sumo pathways. PLoS ONE 2010, 5:e15805.
61. Tokgöz Z, Siepmann TJ, Streich F, Kumar B, Klein JM, Haas AL: E1-E2 
interactions in ubiquitin and Nedd8 ligation pathways. J Biol Chem 2012, 
287:311-321.
62. Huang L, Kinnucan E, Wang G, Beaudenon S, Howley PM, Huibregtse JM, 
Pavletich NP: Structure of an E6AP-UbcH7 complex: insights into 
ubiquitination by the E2-E3 enzyme cascade. Science 1999, 286:1321-1326.
63. Verdecia MA, Joazeiro CAP, Wells NJ, Ferrer J-L, Bowman ME, Hunter T, Noel JP: 
Conformational flexibility underlies ubiquitin ligation mediated by the 
WWP1 HECT domain E3 ligase. Mol Cell 2003, 11:249-259.
64. Kamadurai HB, Souphron J, Scott DC, Duda DM, Miller DJ, Stringer D, Piper RC, 
Schulman BA: Insights into ubiquitin transfer cascades from a structure of 
a UbcH5B approximately ubiquitin-HECT(NEDD4L) complex. Mol Cell 2009, 
36:1095-1102.
65. Kim HC, Steffen AM, Oldham ML, Chen J, Huibregtse JM: Structure and 
function of a HECT domain ubiquitin-binding site. EMBO Rep 2011, 
12:334-341.
66. Ogunjimi AA, Briant DJ, Pece-Barbara N, Le Roy C, Di Guglielmo GM, Kavsak P, 
Rasmussen RK, Seet BT, Sicheri F, Wrana JL: Regulation of Smurf2 ubiquitin 
ligase activity by anchoring the E2 to the HECT domain. Mol Cell 2005, 
19:297-308.
67. Pandya RK, Partridge JR, Love KR, Schwartz TU, Ploegh HL: A structural 
element within the HUWE1 HECT domain modulates self-ubiquitination 
and substrate ubiquitination activities. J Biol Chem 2010, 285:5664-5673.
68. Maspero E, Mari S, Valentini E, Musacchio A, Fish A, Pasqualato S, Polo S: 
Structure of the HECT:ubiquitin complex and its role in ubiquitin chain 
elongation. EMBO Rep 2011, 12:342-349.
69. Diao J, Zhang Y, Huibregtse JM, Zhou D, Chen J: Crystal structure of SopA, a 
Salmonella effector protein mimicking a eukaryotic ubiquitin ligase. Nat 
Struct Mol Biol 2008, 15:65-70.
70. Lin DY-W, Diao J, Zhou D, Chen J: Biochemical and structural studies of a 
HECT-like ubiquitin ligase from Escherichia coli O157:H7. J Biol Chem 2011, 
286:441-449.
71. Lin DY-W, Diao J, Chen J: Crystal structures of two bacterial HECT-like E3 
ligases in complex with a human E2 reveal atomic details of pathogen-
host interactions. Proc Natl Acad Sci U S A 2012, 109:1925-1930.
72. Wang M, Pickart CM: Different HECT domain ubiquitin ligases employ 
distinct mechanisms of polyubiquitin chain synthesis. EMBO J 2005, 
24:4324-4333.
73. Kim HC, Huibregtse JM: Polyubiquitination by HECT E3s and the 
determinants of chain type specificity. Mol Cell Biol 2009, 29:3307-3318.
74. Gallagher E, Gao M, Liu Y-C, Karin M: Activation of the E3 ubiquitin ligase 
Itch through a phosphorylation-induced conformational change. Proc Natl 
Acad Sci U S A 2006, 103:1717-1722.
75. Wiesner S, Ogunjimi AA, Wang H-R, Rotin D, Sicheri F, Wrana JL, Forman-Kay 
JD: Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 
domain. Cell 2007, 130:651-662.
76. Chaugule VK, Burchell L, Barber KR, Sidhu A, Leslie SJ, Shaw GS, Walden H: 
Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J 
2011, 30:2853-2867.
77. Duda DM, Scott DC, Calabrese MF, Zimmerman ES, Zheng N, Schulman BA: 
Structural regulation of cullin-RING ubiquitin ligase complexes. Curr Opin 
Struct Biol 2011, 21:257-264.
78. Saha A, Deshaies RJ: Multimodal activation of the ubiquitin ligase SCF by 
Nedd8 conjugation. Mol Cell 2008, 32:21-31.
79. Yamoah K, Oashi T, Sarikas A, Gazdoiu S, Osman R, Pan Z-Q: Autoinhibitory 
regulation of SCF-mediated ubiquitination by human cullin 1’s C-terminal 
tail. Proc Natl Acad Sci U S A 2008, 105:12230-12235.
80. Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA: Structural 
insights into NEDD8 activation of cullin-RING ligases: conformational 
control of conjugation. Cell 2008, 134:995-1006.
81. Feltham R, Bettjeman B, Budhidarmo R, Mace PD, Shirley S, Condon SM, 
Chunduru SK, McKinlay MA, Vaux DL, Silke J, Day CL: Smac mimetics activate 
the E3 ligase activity of cIAP1 protein by promoting RING domain 
dimerization. J Biol Chem 2011, 286:17015-17028.
82. Dueber EC, Schoeffler AJ, Lingel A, Elliott JM, Fedorova AV, Giannetti AM, 
Zobel K, Maurer B, Varfolomeev E, Wu P, Wallweber HJA, Hymowitz SG, 
Deshayes K, Vucic D, Fairbrother WJ: Antagonists induce a conformational 
change in cIAP1 that promotes autoubiquitination. Science 2011, 
334:376-380.
83. Yin Q, Lin S-C, Lamothe B, Lu M, Lo Y-C, Hura G, Zheng L, Rich RL, Campos AD, 
Myszka DG, Lenardo MJ, Darnay BG, Wu H: E2 interaction and dimerization 
Lorenz et al. BMC Biology 2013, 11:65
http://www.biomedcentral.com/1741-7007/11/65
Page 11 of 12
in the crystal structure of TRAF6. Nat Struct Mol Biol 2009, 16:658-666.
84. Swaminathan G, Tsygankov AY: The Cbl family proteins: ring leaders in 
regulation of cell signaling. J Cell Physiol 2006, 209:21-43.
85. Ryan PE, Davies GC, Nau MM, Lipkowitz S: Regulating the regulator: 
negative regulation of Cbl ubiquitin ligases. Trends Biochem Sci 2006, 
31:79-88.
86. Meng W, Sawasdikosol S, Burakoff SJ, Eck MJ: Structure of the amino-
terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. 
Nature 1999, 398:84-90.
87. Kuriyan J, Darnell JE: An SH2 domain in disguise. Nature 1999, 398:22-3-25.
88. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, 
Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y: Ubiquitin ligase activity 
and tyrosine phosphorylation underlie suppression of growth factor 
signaling by c-Cbl/Sli-1. Mol Cell 1999, 4:1029-1040.
89. Rao N, Lupher ML, Ota S, Reedquist KA, Druker BJ, Band H: The linker 
phosphorylation site Tyr292 mediates the negative regulatory effect of 
Cbl on ZAP-70 in T cells. J Immunol 2000, 164:4616-4626.
90. Schmidt MHH, Dikic I: The Cbl interactome and its functions. Nat Rev Mol 
Cell Biol 2005, 6:907-918.
91. Zheng N, Wang P, Jeffrey PD, Pavletich NP: Structure of a c-Cbl-UbcH7 
complex: RING domain function in ubiquitin-protein ligases. Cell 2000, 
102:533-539.
92. Umebayashi K, Stenmark H, Yoshimori T: Ubc4/5 and c-Cbl continue to 
ubiquitinate EGF receptor after internalization to facilitate 
polyubiquitination and degradation. Mol Biol Cell 2008, 19:3454-3462.
93. Huang A, de Jong RN, Wienk H, Winkler GS, Timmers HTM, Boelens R: E2-c-
Cbl recognition is necessary but not sufficient for ubiquitination activity. J 
Mol Biol 2009, 385:507-519.
94. Yokouchi M, Kondo T, Sanjay A, Houghton A, Yoshimura A, Komiya S, Zhang 
H, Baron R: Src-catalyzed phosphorylation of c-Cbl leads to the 
interdependent ubiquitination of both proteins. J Biol Chem 2001, 
276:35185-35193.
95. Liu J, Kimura A, Baumann CA, Saltiel AR: APS facilitates c-Cbl tyrosine 
phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 
adipocytes. Mol Cell Biol 2002, 22:3599-3609.
96. Kassenbrock CK, Anderson SM: Regulation of ubiquitin protein ligase 
activity in c-Cbl by phosphorylation-induced conformational change and 
constitutive activation by tyrosine to glutamate point mutations. J Biol 
Chem 2004, 279:28017-28027.
97. Bartkiewicz M, Houghton A, Baron R: Leucine zipper-mediated 
homodimerization of the adaptor protein c-Cbl. A role in c-Cbl’s tyrosine 
phosphorylation and its association with epidermal growth factor 
receptor. J Biol Chem 1999, 274:30887-30895.
98. Peschard P, Kozlov G, Lin T, Mirza IA, Berghuis AM, Lipkowitz S, Park M, 
Gehring K: Structural basis for ubiquitin-mediated dimerization and 
activation of the ubiquitin protein ligase Cbl-b. Mol Cell 2007, 27:474-485.
99. Kozlov G, Peschard P, Zimmerman B, Lin T, Moldoveanu T, Mansur-Azzam N, 
Gehring K, Park M: Structural basis for UBA-mediated dimerization of c-Cbl 
ubiquitin ligase. J Biol Chem 2007, 282:27547-27555.
100. Fischer ES, Scrima A, Böhm K, Matsumoto S, Lingaraju GM, Faty M, Yasuda T, 
Cavadini S, Wakasugi M, Hanaoka F, Iwai S, Gut H, Sugasawa K, Thomä NH: 
The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, 
targeting, and activation. Cell 2011, 147:1024-1039.
101. Calabrese MF, Scott DC, Duda DM, Grace CRR, Kurinov I, Kriwacki RW, 
Schulman BA: A RING E3-substrate complex poised for ubiquitin-like 
protein transfer: structural insights into cullin-RING ligases. Nat Struct Mol 
Biol 2011, 18:947-949.
102. Liu J, Nussinov R: Flexible cullins in cullin-RING E3 ligases allosterically 
regulate ubiquitination. J Biol Chem 2011, 286:40934-40942.
103. Chao WCH, Kulkarni K, Zhang Z, Kong EH, Barford D: Structure of the mitotic 
checkpoint complex. Nature 2012, 484:208-213.
104. Herzog F, Primorac I, Dube P, Lenart P, Sander B, Mechtler K, Stark H, Peters 
J-M: Structure of the anaphase-promoting complex/cyclosome interacting 
with a mitotic checkpoint complex. Science 2009, 323:1477-1481.
105. Olsen SK, Lima CD: Structure of a ubiquitin E1-E2 complex: insights to 
E1-E2 thioester transfer. Mol Cell 2013, 49:884-896.
Lorenz et al. BMC Biology 2013, 11:65
http://www.biomedcentral.com/1741-7007/11/65
doi:10.1186/1741-7007-11-65
Cite this article as: Lorenz S, et al.: Macromolecular juggling by 
ubiquitylation enzymes. BMC Biology 2013, 11:65.
Page 12 of 12
